Content about Maryland

October 22, 2013

Researchers have begun the first definitive, large-scale clinical trial to investigate if a vitamin D supplement helps prevent or delay Type 2 diabetes in adults who have prediabetes and are at high risk for developing Type 2.

BETHESDA, Md. — Researchers have begun the first definitive, large-scale clinical trial to investigate if a vitamin D supplement helps prevent or delay Type 2 diabetes in adults who have prediabetes and are at high risk for developing Type 2. Funded by the National Institutes of Health, the study is taking place at about 20 study sites across the United States, the agency announced Monday.

October 21, 2013

The Food and Drug Administration has approved a new drug made by Actelion Pharmaceuticals for treating pulmonary arterial hypertension.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Actelion Pharmaceuticals for treating pulmonary arterial hypertension.

The agency announced the approval of Opsumit (macitentan) for adults with PAH, a chronic, progressive and debilitating disease caused by high blood pressure in the arteries that connect the heart to the lungs that can lead to death or the need for lung transplantation.

October 21, 2013

The Food and Drug Administration is offering more than $14 million in grants for the development of products for patients with rare diseases, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration is offering more than $14 million in grants for the development of products for patients with rare diseases, the agency said Monday.

October 17, 2013

Procter & Gamble’s CoverGirl has tapped music star Katy Perry to be the newest face of the beauty brand.

HUNT VALLEY, Md. — Procter & Gamble’s CoverGirl has tapped music star Katy Perry to be the newest face of the beauty brand.

October 10, 2013

One of the Food and Drug Administration's top regulators is not retiring, contrary to rumors reported in news media Thursday.

SILVER SPRING, Md. – One of the Food and Drug Administration's top regulators is not retiring, contrary to rumors reported in news media Thursday.

In a memo sent out to staff, Center for Drug Evaluation and Research director Janet Woodcock wrote that she would not retire, but was becoming "more deeply involved" in such activities as proposed reorganizations of the Office of Pharmaceutical Quality and the Office of Generic Drugs.

October 10, 2013

Giant Food of Landover, Md., presented its first-ever Giant Food NextGen Award for Children's Cancer Research this week, created for young investigators committed to pursuing a long-term career in pediatric oncology research.

LANDOVER, Md. — Giant Food of Landover, Md., presented its first-ever Giant Food NextGen Award for Children's Cancer Research this week, created for young investigators committed to pursuing a long-term career in pediatric oncology research.

October 10, 2013

Even the most savvy sunscreen user can forget to reapply sunscreen when having fun in the sun. However, remembering to reapply is even easier with the licensed sunscreen bands from JADS International.

HUNT VALLEY, Md. — Even the most savvy sunscreen user can forget to reapply sunscreen when having fun in the sun. However, remembering to reapply is even easier with the licensed sunscreen bands from JADS International. JADS partnered with Marvel, Lifeguard, Alloy Entertainment and Save the Ta-tas to design fashionable bands that appeal to kids and adults alike. Sunscreen Bands’ patented color-changing technology detects the level of UVA and UVB rays based onthe SPF level of an individual's sunscreen.

October 9, 2013

The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

SILVER SPRING, Md. — The Food and Drug Administration today approved Adempas, also known as riociguat, to treat adults with two forms of pulmonary hypertension, which is caused by abnormally high blood pressure in the arteries of the lungs.

October 8, 2013

The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for hot flashes and the prevention of osteoporosis, the agency said.

The FDA announced the approval of Duavee (conjugated estrogens; bazedoxifene), made by Pfizer. The drug is for women who suffer from moderate to severe hot flashes associated with menopause, and is also designed to prevent osteoporosis after menopause.

October 8, 2013

USO's division for the nation's capital has named supermarket chain Giant Food of Landover, Md., to its USO-Metro 2013 Circle of the Stars for an annual networking event, the chain said.

LANDOVER, Md. — USO's division for the nation's capital has named supermarket chain Giant Food of Landover, Md., to its USO-Metro 2013 Circle of the Stars for an annual networking event, the chain said.

October 4, 2013

Giant Food Stores turned 90 Friday, the Ahold USA-owned supermarket chain said.

CARLISLE, Pa. — Giant Food Stores turned 90 Friday, the Ahold USA-owned supermarket chain said.

The supermarket banner, which operates nearly 200 stores under the Giant and Martin's Food Markets brands in Pennsylvania, Maryland, Virginia and West Virginia, marked its 90th anniversary Friday morning at a store in its hometown of Carlisle, Pa. Customers at all the company's 200 stores will receive free slices of cake and free apple slices Friday.

October 3, 2013

The Food and Drug Administration is requiring Johnson & Johnson to use long-lasting ink in the labeling and dosage strength of an opioid painkiller patch it markets in order to make it easier to see.

SILVER SPRING, Md. — The Food and Drug Administration is requiring Johnson & Johnson to use long-lasting ink in the labeling and dosage strength of an opioid painkiller patch it markets in order to make it easier to see.

October 1, 2013

The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug developed by Takeda to treat major depressive disorder, the agency said.

The FDA announced the approval of Brintellix (vortioxetine) tablets for treating MDD in adults. The drug will be available in the 5-mg, 10-mg, 15-mg and 20-mg strengths.

September 30, 2013

The Food and Drug Administration has approved a drug for treating early-stage breast cancer before surgery, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for treating early-stage breast cancer before surgery, the agency said Monday.

September 27, 2013

FlavoRx will start recognizing independent pharmacies that have implemented its program next month, the company said Friday.

COLUMBIA, Md. — FlavoRx will start recognizing independent pharmacies that have implemented its program next month, the company said Friday.

FlavoRx, which makes flavorings that pharmacists can add to drugs, announced the inaugural FlavoRx Independent Pharmacy of the Year award, to be presented every October.

September 26, 2013

The former president of Giant Food of Landover, Md., has joined Schnuck Markets as EVP and chief strategy officer, Schnucks said Thursday.

ST. LOUIS — The former president of Giant Food of Landover, Md., has joined Schnuck Markets as EVP and chief strategy officer, Schnucks said Thursday.

September 26, 2013

Pharmagen on Thursday announced the launch of Clotamin, a unique multivitamin formulated without vitamin K in order to meet the special nutritional needs of people taking blood-thinning medications (anticoagulants), such as Warfarin.

SILVER SPRING, Md. — Pharmagen on Thursday announced the launch of Clotamin, a unique multivitamin formulated without vitamin K in order to meet the special nutritional needs of people taking blood-thinning medications (anticoagulants), such as Warfarin. 

Because it does not contain vitamin K, Clotamin can be taken with Warfarin without affecting international normalized ratio levels. 

September 25, 2013

Foods must carry gluten content of less than 20 parts per million in order to carry the label "gluten-free," according to a new regulation issued by the Food and Drug Administration.

SILVER SPRING, Md. — Foods must carry gluten content of less than 20 parts per million in order to carry the label "gluten-free," according to a new regulation issued by the Food and Drug Administration.

The FDA announced the regulation Wednesday, saying the standard would provide consumers with the assurance that "gluten-free" claims on product labeling are consistent and reliable across the food industry; other labels, such as "no gluten" and "without gluten" also would be subject to the new standard.

September 23, 2013

Royal Ahold supervisory board member Tom de Swaan will resign as of the end of this month, the company said Monday.

ZAANDAM, Netherlands — Royal Ahold supervisory board member Tom de Swaan will resign at the end of this month, the company said Monday.

Netherlands-based Ahold, the parent company of Ahold USA and U.S. supermarket banners Stop & Shop, Giant Food of Landover, Md., and Giant Food Stores of Carlisle, Pa., as well as the online grocer Peapod, said de Swaan would resign effective Sept. 30.

September 23, 2013

The Food and Drug Administration will not enforce regulatory requirements for most mobile medical apps because they "post minimal risk to consumers," the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration will not enforce regulatory requirements for most mobile medical apps because they "post minimal risk to consumers," the agency said Monday.

The FDA announced the issuance of guidance on the apps, saying it would adopt a "tailored policy" toward regulation, focusing its regulatory oversight on those apps that present greater risk if they do not work as intended.

September 19, 2013

A new research institution set up by the federal government will conduct tobacco-related research around the country using more than $50 million from the Food and Drug Administration and the National Institutes of Health.

SILVER SPRING, Md. — A new research institution set up by the federal government will conduct tobacco-related research around the country using more than $50 million from the Food and Drug Administration and the National Institutes of Health.

September 19, 2013

Inovalon and Walgreens on Thursday announced that they have entered into a multi-year agreement to provide Inovalon's data-driven encounter support platform, Electronic Patient Assessment Solution Suite (ePASS) within Healthcare Clinic at select Walgreens to support improvements in managed care quality and performance.

BOWIE, Md. — Inovalon and Walgreens on Thursday announced that they have entered into a multi-year agreement to provide Inovalon's data-driven encounter support platform, Electronic Patient Assessment Solution Suite (ePASS) within Healthcare Clinic at select Walgreens to support improvements in managed care quality and performance.

September 16, 2013

The Food and Drug Administration has approved a generic chemotherapy pill for treating colorectal and breast cancers, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a generic chemotherapy pill for treating colorectal and breast cancers, the agency said Monday.

The FDA announced the approval of Teva Pharmaceutical Industries' capecitabine tablets in the 150-mg and 500-mg strengths. The drug is used to treat cancers that have metastasized, meaning they've spread to other parts of the body.

The drug is a generic version of Xeloda, made by Roche division Genentech. According to IMS Health, Xeloda had sales of $706.2 million last year.

 

September 16, 2013

The Food and Drug Administration is barring the importation of drugs from another one of Ranbaxy Labs' plants in India, the agency said Monday.

SILVER SPRING, Md. – The Food and Drug Administration is barring the importation of drugs from another one of Ranbaxy Labs' plants in India, the agency said Monday.

September 13, 2013

Companies that make long-acting opioid painkillers will be required to conduct studies to assess their safety, while use of the drugs will be restricted, under new requirements from the Food and Drug Administration.

SILVER SPRING, Md. — Companies that make long-acting opioid painkillers will be required to conduct studies to assess their safety, while use of the drugs will be restricted, under new requirements from the Food and Drug Administration.

The agency announced new labeling changes and regulatory requirements for makers of extended-release and long-acting opioids, citing the risk the drugs carry of overdose, abuse and withdrawal. In response, a group also cautioned consumers to be careful when using non-steroidal anti-inflammatory drugs.